Total Payments
$15,451
2024 Payments
$1,729
Companies
42
Transactions
232
Medicare Patients
1,850
Medicare Billing
$247,725
Payment Breakdown by Category
Consulting$10,200 (66.0%)
Food & Beverage$3,932 (25.4%)
Travel$1,128 (7.3%)
Education$190.58 (1.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $10,200 | 1 | 66.0% |
| Food and Beverage | $3,932 | 225 | 25.4% |
| Travel and Lodging | $1,128 | 3 | 7.3% |
| Education | $190.58 | 3 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ADC Therapeutics America, Inc. | $11,477 | 7 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $479.84 | 37 | $0 (2024) |
| PFIZER INC. | $357.60 | 21 | $0 (2024) |
| Janssen Biotech, Inc. | $271.13 | 15 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $249.45 | 17 | $0 (2024) |
| Astellas Pharma US Inc | $237.57 | 9 | $0 (2024) |
| Gilead Sciences, Inc. | $213.97 | 13 | $0 (2024) |
| Seagen Inc. | $209.25 | 18 | $0 (2023) |
| Amgen Inc. | $138.54 | 5 | $0 (2019) |
| Incyte Corporation | $138.23 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,729 | 93 | PFIZER INC. ($268.53) |
| 2023 | $633.15 | 40 | Seagen Inc. ($176.30) |
| 2022 | $11,478 | 9 | ADC Therapeutics America, Inc. ($11,425) |
| 2021 | $15.49 | 1 | Janssen Biotech, Inc. ($15.49) |
| 2020 | $256.49 | 10 | Incyte Corporation ($121.77) |
| 2019 | $896.90 | 57 | Astellas Pharma US Inc ($167.80) |
| 2018 | $372.02 | 21 | Amgen Inc. ($105.61) |
| 2017 | $69.25 | 1 | Foundation Medicine, Inc. ($69.25) |
All Payment Transactions
232 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $33.22 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/17/2024 | Geron Corporation | RYTELO (Drug) | Food and Beverage | In-kind items and services | $25.75 | General |
| Category: MYELODYSPLASTIC SYNDROME | ||||||
| 12/05/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Oncology | ||||||
| 12/03/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $0.85 | General |
| Category: ONCOLOGY | ||||||
| 11/25/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Oncology | ||||||
| 11/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.21 | General |
| 11/20/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.08 | General |
| 11/13/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: DESMOID TUMORS | ||||||
| 11/12/2024 | Genentech USA, Inc. | Itovebi (Biological), Perjeta, Phesgo | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: BioOncology | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $9.14 | General |
| Category: Oncology | ||||||
| 10/25/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 10/22/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: Oncology | ||||||
| 10/22/2024 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: CELLT | ||||||
| 10/17/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY, DARZALEX | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Oncology | ||||||
| 10/15/2024 | PFIZER INC. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: Oncology | ||||||
| 10/14/2024 | E.R. Squibb & Sons, L.L.C. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $23.42 | General |
| Category: Oncology | ||||||
| 10/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $4.48 | General |
| 10/03/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Oncology | ||||||
| 10/01/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ALUNBRIG (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 404 | 762 | $97,935 | $66,628 |
| 2022 | 8 | 443 | 804 | $98,559 | $68,079 |
| 2021 | 12 | 507 | 876 | $108,629 | $68,821 |
| 2020 | 12 | 496 | 773 | $88,999 | $44,197 |
Total Patients
1,850
Total Services
3,215
Medicare Billing
$247,725
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 111 | 351 | $51,344 | $37,066 | 72.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 137 | 217 | $21,171 | $15,249 | 72.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 35 | 35 | $7,075 | $4,833 | 68.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 82 | 94 | $6,898 | $4,269 | 61.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 12 | 34 | $6,409 | $3,197 | 49.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 16 | $3,988 | $1,647 | 41.3% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2023 | 11 | 15 | $1,050 | $367.19 | 35.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 111 | 362 | $50,741 | $37,540 | 74.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 130 | 194 | $18,648 | $12,770 | 68.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 38 | 38 | $7,562 | $5,403 | 71.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 105 | 117 | $7,631 | $4,872 | 63.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 33 | $5,082 | $2,664 | 52.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 30 | $3,270 | $1,698 | 51.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 15 | $3,300 | $1,607 | 48.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 15 | 15 | $2,325 | $1,524 | 65.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 80 | 285 | $41,691 | $30,063 | 72.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 115 | 182 | $18,402 | $13,035 | 70.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 114 | 145 | $9,821 | $6,103 | 62.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 34 | 34 | $7,203 | $4,692 | 65.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 35 | 35 | $5,493 | $3,674 | 66.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 20 | 44 | $7,280 | $3,429 | 47.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 24 | 55 | $6,413 | $2,961 | 46.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 16 | 16 | $3,578 | $1,697 | 47.4% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 17 | 18 | $2,542 | $1,446 | 56.9% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 13 | 20 | $1,452 | $607.40 | 41.8% |
About Dr. Ethan Binder, M.D
Dr. Ethan Binder, M.D is a Internal Medicine healthcare provider based in Rio Rancho, New Mexico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2012. The National Provider Identifier (NPI) number assigned to this provider is 1598028540.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ethan Binder, M.D has received a total of $15,451 in payments from pharmaceutical and medical device companies, with $1,729 received in 2024. These payments were reported across 232 transactions from 42 companies. The most common payment nature is "Consulting Fee" ($10,200).
As a Medicare-enrolled provider, Binder has provided services to 1,850 Medicare beneficiaries, totaling 3,215 services with total Medicare billing of $247,725. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology
- Location Rio Rancho, NM
- Active Since 06/24/2012
- Last Updated 06/14/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1598028540
Products in Payments
- PADCEV (Biological) $271.88
- KISQALI (Drug) $176.57
- IMBRUVICA (Drug) $152.37
- MONJUVI (Drug) $121.77
- DARZALEX (Biological) $111.84
- Yescarta (Drug) $109.29
- PROMACTA (Drug) $105.92
- OPDIVO (Biological) $98.17
- ADCETRIS (Biological) $91.10
- KEYTRUDA (Biological) $84.68
- VENCLEXTA (Drug) $82.95
- FOUNDATIONONE (Device) $80.96
- Kyprolis (Biological) $77.95
- XTANDI (Drug) $77.69
- PLUVICTO (Drug) $76.42
- Lenvima (Drug) $72.58
- GILOTRIF (Drug) $71.42
- XOSPATA (Drug) $68.80
- TAGRISSO (Drug) $66.07
- KRAZATI (Drug) $60.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Rio Rancho
Dr. Sri Rama Krishna Paruchuri, M.d, M.D
Internal Medicine — Payments: $3,291
Internal Medicine $3,291
Dr. Salvador Garcia, Md, MD
Internal Medicine — Payments: $3,059
Internal Medicine $3,059
Robert Gardner, Md, MD
Internal Medicine — Payments: $1,587
Internal Medicine $1,587
Christina Haaland, Md Phd, MD PHD
Internal Medicine — Payments: $1,204
Internal Medicine $1,204
Dr. Ebubechukwu Njemanze, M.d, M.D
Internal Medicine — Payments: $365.17
Internal Medicine $365.17
Mr. Jeremy Durling, Md, MD
Internal Medicine — Payments: $185.58
Internal Medicine $185.58